EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Sensitizing carbapenem-resistant Klebsiella pneumoniae using a compact Cascade-Cas3 system

Jun Huang, Jiahui Chen, Luyao Huang, Shaofu Qiu, Ligui Wang, Xinying Du, Chao Wang, Zhengquan Yuan, Ping Li, Hongbin Song, Hongbo Liu

International Microbiology · 2026

DOI: 10.1007/s10123-026-00846-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Microbiology, 2026. Verfasst von Jun Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease Prevention and Control, Chinese PLA Center for Disease Control and Prevention, Beijing, China. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Anti-Bacterial Agents, Carbapenems, CRISPR-Cas Systems. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science Foundation of China, National Science and Technology Major Project of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Klebsiella pneumoniae is a 'superbug' characterized by high virulence and carbapenem resistance. CRISPR-Cas3 is capable of performing large-scale deletions in bacterial genomes. The purpose of this study is to sensitize Klebsiella pneumoniae A324 to carbapenem antibiotics by eliminating the multidrug resistance plasmid pA324-IMP using a compact Cascade-Cas3 system. METHODS: Recombinant plasmids were constructed using molecular cloning techniques. Three sgRNAs targeting different positions within the blaIMP-38 gene were designed. Recombinant plasmids were separately transformed into host bacteria carrying blaIMP38 genes. The elimination efficiency of each CRISPR-Cas3 system target was determined by PCR and qPCR. Fluorescence confocal microscopy was used to observe the fluorescence intensity. Bacterial drug susceptibility phenotypes were determined using E-test drug sensitivity strips. RESULTS: In this study, we successfully constructed the high copy number plasmid, the fluorescent plasmid, and the recombinant CRISPR plasmids. PCR and qPCR results demonstrated that the CRISPR-Cas3 system could efficiently eliminate blaIMP-38 genes, with pCas3-T3 showing the highest elimination efficiency. Fluorescence confocal microscopy indicated that the fluorescence intensity of the experimental group significantly decreased compared to the control group. Additionally, drug susceptibility tests revealed that the resistance of Klebsiella pneumoniae to imipenem and meropenem was significantly reduced. Furthermore, CRISPR-Cas3 could enhance the effectiveness of meropenem in killing Klebsiella pneumoniae A324. CONCLUSION: In conclusion, this work demonstrates that the compact Cascade-Cas3 system can serve as a novel tool to eliminate the resistance gene blaIMP-38 and restore the sensitivity of host bacteria to antibiotics. This strategy shows great potential to combat the spread of the blaIMP-38 gene in Klebsiella pneumoniae and holds significant application value in the field of combating drug-resistant bacteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeAnti-Bacterial AgentsCarbapenemsCRISPR-Cas SystemsCarbapenem-Resistant EnterobacteriaceaePlasmidsMicrobial Sensitivity TestsKlebsiella InfectionsBacterial Proteinsbeta-Lactamases

Stichwörter der Autor:innen

Klebsiella pneumoniaeAntimicrobial resistanceCRISPR-Cas3PA324-IMP plasmid

Substanzen

Anti-Bacterial AgentsCarbapenemsBacterial Proteinsbeta-Lactamases

Autor:innen und Institutionen

  • Department of Infectious Disease Prevention and Control, Chinese PLA Center for Disease Control and Prevention, Beijing, China.
  • Department of Human Anatomy and Histology, School of Basic Medicine, Capital Medical University, Beijing, China.
  • Department of Epidemiology, School of Public Health, China Medical University, Shenyang, China.
  • Department of Infectious Disease Prevention and Control, Chinese PLA Center for Disease Control and Prevention, Beijing, China. yzq66@sohu.com.
  • Department of Stomatology, the Eighth Medical Center of PLA General Hospital, Beijing, China. 757265702@qq.com.
  • Department of Infectious Disease Prevention and Control, Chinese PLA Center for Disease Control and Prevention, Beijing, China. hongbinsong@263.net.

Förderung

  • National Science Foundation of China
  • National Science and Technology Major Project of China

Zitieren

APA

Huang, J., Chen, J., Huang, L., Qiu, S., Wang, L., Du, X., Wang, C., Yuan, Z., Li, P., Song, H., & Liu, H. (2026). Sensitizing carbapenem-resistant Klebsiella pneumoniae using a compact Cascade-Cas3 system. International Microbiology. https://doi.org/10.1007/s10123-026-00846-9

Vancouver

Huang J, Chen J, Huang L, Qiu S, Wang L, Du X, et al. Sensitizing carbapenem-resistant Klebsiella pneumoniae using a compact Cascade-Cas3 system. International Microbiology. 2026. doi:10.1007/s10123-026-00846-9

BibTeX
@article{Huang2026,
  author = {Huang, Jun and Chen, Jiahui and Huang, Luyao and Qiu, Shaofu and Wang, Ligui and Du, Xinying and Wang, Chao and Yuan, Zhengquan and Li, Ping and Song, Hongbin and Liu, Hongbo},
  title = {Sensitizing carbapenem-resistant Klebsiella pneumoniae using a compact Cascade-Cas3 system},
  journal = {International Microbiology},
  year = {2026},
  doi = {10.1007/s10123-026-00846-9}
}
Kostenlos starten →